[6] Tirzepatide (e.g., Zepbound, Mounjaro for off-label use): Also a once-weekly injectable, Tirzepatide is a unique dual agonist, meaning it mimics both GLP-1 and GIP (Glucose-dependent Insulinotropic Polypeptide)
Dondero, Andrology: Placebo-controlled, double-blind, cross-over trial of glutathione (GSH) therapy in male infertility, Human Reproduction, Volume 8, Issue 10, October 1993, Pages 16571662 *Adeoye O, Olawumi J, Opeyemi A, Christiania O
Anvndare i Nederlnderna kan kontakta Autoriteit Persoonsgegevens (AP) p www.autoriteitpersoonsgegevens.nl
Tirzepatide, a dual GIP and GLP-1 receptor agonist, extended this concept by demonstrating even greater weight reduction in adults with obesity or overweight